Menu
Enrolling by invitation NCT05156151

Stromal Lenticule Implantation for Management of Herpetic Stromal Keratitis

No phase Interventional Stromal Keratitis

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Relex-Smile.
Who it may be relevant to
Registry conditions: Stromal Keratitis. Basic parameters: 21 years — 46 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Kosovo
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

The aim of this study is the evaluation of corneal transparency and improvement of visual acuity in patients with herpetic stromal keratitis.

Detailed description

Stromal keratitis is an infectious ocular disease of either necrotizing or non-necrotizing form, due to an HSV infection, and characterized by corneal stromal necrosis, inflammation, ulceration and infiltration by leukocytes.

In our study these early findings suggest that the use of corneal stromal lenticules with stromal stem cells and live keratocytes could be a safe and efficient treatment for stromal scar after herpetic keratitis, and excluding the recurrence of the disease by removing the corneal scar after herpetic infection using Smile and implanting the lenticule equal to the volume of the removed scar tissue.

Stromal lenticule implantation is relatively simple, low-cost and offers advantages over corneal transplantation as a definitive procedure in the treatment of this disease.

Interventions

  • Other Relex-Smile

Primary outcome measures

  • Corneal transparency [Time frame: 12 months]
Secondary outcome measures (1)
  • Evaluation of visual acuity [Time frame: 12 months]

Eligibility criteria

Inclusion criteria

  • low transparenc of cornea
  • low visual acuity
  • recurrence of herpetic stromal keratitis

Exclusion criteria

  • previous corneal or anterior segment surgery
  • any infection

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

Kosovo · 1 center
  • Eye Hospital Pristina — Pristina

Identifiers

NCT: NCT05156151 · EyehospitalPrishtina

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗